Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marieke F Fransen

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2020
Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor ImmunotherapyMark J A Schoonderwoerd, Maaike F M Koops, Ricardo A Angela, et al.
EMBO Molecular Medicine|November 9, 2023
Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencingYmke van der Pol, Normastuti Adhini Tantyo, Nils Evander, et al.
Science Translational Medicine|March 13, 2020
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapyMaud Mayoux, Andreas Roller, Vesna Pulko, et al.
Science Immunology|July 20, 2022
Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic T<sub>reg</sub> reduction and effector T cell activationKim M van Pul, Jessica C L Notohardjo, Marieke F Fransen, et al.
Journal for Immunotherapy of Cancer|September 30, 2024
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE studyIdris Bahce, Chris Dickhoff, Famke L Schneiders, et al.
Cancer Immunology Research|June 27, 2023
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell-Mediated Immune Response against EGFR-Expressing TumorsLisa A King, Elisa C Toffoli, Myrthe Veth, et al.
Science Advances|September 7, 2019
Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineeringJohan M S van der Schoot, Felix L Fennemann, Michael Valente, et al.
Molecular Cancer|December 16, 2023
Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumorsPhilipp Knopf, Dimitri Stowbur, Sabrina H L Hoffmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2018
A Restricted Role for FcγR in the Regulation of Adaptive ImmunityMarieke F Fransen, Hreinn Benonisson, Wendy W van Maren, et al.
European Journal of Immunology|December 13, 2024
Guidelines for preparation and flow cytometry analysis of human nonlymphoid tissue DCDiana Dudziak, Lukas Heger, William W Agace, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2020
Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor ImmunotherapyMark J A Schoonderwoerd, Maaike F M Koops, Ricardo A Angela, et al.
EMBO Molecular Medicine|November 9, 2023
Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencingYmke van der Pol, Normastuti Adhini Tantyo, Nils Evander, et al.
Science Translational Medicine|March 13, 2020
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapyMaud Mayoux, Andreas Roller, Vesna Pulko, et al.
Science Immunology|July 20, 2022
Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic T<sub>reg</sub> reduction and effector T cell activationKim M van Pul, Jessica C L Notohardjo, Marieke F Fransen, et al.
Journal for Immunotherapy of Cancer|September 30, 2024
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE studyIdris Bahce, Chris Dickhoff, Famke L Schneiders, et al.
Cancer Immunology Research|June 27, 2023
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell-Mediated Immune Response against EGFR-Expressing TumorsLisa A King, Elisa C Toffoli, Myrthe Veth, et al.
Science Advances|September 7, 2019
Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineeringJohan M S van der Schoot, Felix L Fennemann, Michael Valente, et al.
Molecular Cancer|December 16, 2023
Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumorsPhilipp Knopf, Dimitri Stowbur, Sabrina H L Hoffmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2018
A Restricted Role for FcγR in the Regulation of Adaptive ImmunityMarieke F Fransen, Hreinn Benonisson, Wendy W van Maren, et al.
European Journal of Immunology|December 13, 2024
Guidelines for preparation and flow cytometry analysis of human nonlymphoid tissue DCDiana Dudziak, Lukas Heger, William W Agace, et al.
Pageof 6